Oral and Maxillofacial Hemangioma Laser Treatment

Oral and Maxillofacial Hemangioma (OHs) are benign tumors that develop due to endothelial cell proliferation and occur in and around the oral cavity.

While 60 to 70 percent of hemangiomas occur in the head and neck region, OHs are relatively rare and most frequently involve the lips, tongue, buccal mucosa, and palate.

Although there are many treatment approaches for curing this lesion such as; surgery, cryotherapy, sclerosant agents, laser therapy has more advantages in comparison to the other methods. Such as hemostasis and clean operating field, decreased amount of pain and oedema.

Several laser machines are being constantly manufactured to fulfil these functions. The FDA Portable 980nm Surgery Laser System SIFLASER-1.2B has for long been a top choice for Maxillofacial surgeons.

This device displays a unique feature. Its blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm, this machine can perform better and gentler benign tumors’ cutting, even at lower power.

As such, its improved cutting performance makes it ideally suited to all surgical applications, particularly for Oral and Maxillofacial benign tumors.

What also makes the SIFLASER-1.2B highly recommended by Maxillofacial surgeons is that it displays an accurate alignment and exact sighting during the treatment/surgery. All thanks to its green aiming beam.

Also, for better results, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses.

Additionally, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.

With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly suit this benign tumor quite sensitive surgeries.

Such a quality is also expected to reduce thermal damage due to its peculiar interaction with haemoglobin.

Due to all these features, the SIFLASER-1.2 B guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.

Since their invention, laser applications have expanded rapidly as they proved to be a successful addition to cancer/benign tumors surgeries.  

In this article, we discuss the benefits of laser therapy and precisely the efficacy of SIFLASER-1.2B as a surgical laser device in treating Oral and Maxillofacial Hemangioma.

Reference: Laser Treatment of Oral and Maxillofacial Hemangioma

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.